InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.060
-0.040 (-3.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
InflaRx Stock Forecast
IFRX's stock price has decreased by -55.27% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for InflaRx stock have an average target of 8.50, with a low estimate of 2.00 and a high estimate of 22. The average target predicts an increase of 701.89% from the current stock price of 1.06.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for InflaRx stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $5 → $2 | Buy → Hold | Downgrades | $5 → $2 | +88.68% | Dec 3, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $10 → $22 | Strong Buy | Maintains | $10 → $22 | +1,975.47% | Nov 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +466.04% | Sep 2, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $6 → $3 | Buy | Maintains | $6 → $3 | +183.02% | May 29, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $6 | Buy | Initiates | $6 | +466.04% | May 8, 2025 |
Financial Forecast
Revenue This Year
69.19K
from 165.79K
Decreased by -58.27%
Revenue Next Year
813.24K
from 69.19K
Increased by 1,075.42%
EPS This Year
-0.69
from -0.78
EPS Next Year
-0.69
from -0.69
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 133,350 | 5.4M | ||||
| Avg | 69,187 | 813,236 | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -19.6% | 7,661.6% | ||||
| Avg | -58.3% | 1,075.4% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.65 | -0.47 | ||||
| Avg | -0.69 | -0.69 | ||||
| Low | -0.72 | -1.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.